These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27071042)

  • 1. Differences in Clinical Features of Methamphetamine Users with Persistent Psychosis and Patients with Schizophrenia.
    Wang LJ; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Chen CK
    Psychopathology; 2016; 49(2):108-15. PubMed ID: 27071042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-Rank Symptoms in Methamphetamine Psychosis and Schizophrenia.
    Shelly J; Uhlmann A; Sinclair H; Howells FM; Sibeko G; Wilson D; Stein DJ; Temmingh H
    Psychopathology; 2016; 49(6):429-435. PubMed ID: 27926911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use.
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Psychiatry Res; 2021 Apr; 298():113760. PubMed ID: 33548691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses.
    Voce A; McKetin R; Burns R; Castle D; Calabria B
    Psychiatry Res; 2018 Jul; 265():19-24. PubMed ID: 29680513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic schizophrenia-like states in methamphetamine psychosis.
    Tomiyama G
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):531-9. PubMed ID: 2074612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of transient versus persistent psychotic symptoms among dependent methamphetamine users.
    McKetin R; Gardner J; Baker AL; Dawe S; Ali R; Voce A; Leach LS; Lubman DI
    Psychiatry Res; 2016 Apr; 238():166-171. PubMed ID: 27086229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatients.
    Zarrabi H; Khalkhali M; Hamidi A; Ahmadi R; Zavarmousavi M
    BMC Psychiatry; 2016 Feb; 16():44. PubMed ID: 26911516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotic symptoms in methamphetamine psychotic in-patients.
    Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The profile of psychiatric symptoms exacerbated by methamphetamine use.
    McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
    Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis
    Voce A; Calabria B; Burns R; Castle D; McKetin R
    Subst Use Misuse; 2019; 54(4):549-559. PubMed ID: 30693832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary and substance-induced psychotic disorders in methamphetamine users.
    Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.
    Chen CK; Lin SK; Sham PC; Ball D; Loh EW; Hsiao CC; Chiang YL; Ree SC; Lee CH; Murray RM
    Psychol Med; 2003 Nov; 33(8):1407-14. PubMed ID: 14672249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis.
    Sato M; Chen CC; Akiyama K; Otsuki S
    Biol Psychiatry; 1983 Apr; 18(4):429-40. PubMed ID: 6860719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typologies of positive psychotic symptoms in methamphetamine dependence.
    Bousman CA; McKetin R; Burns R; Woods SP; Morgan EE; Atkinson JH; Everall IP; Grant I;
    Am J Addict; 2015 Mar; 24(2):94-97. PubMed ID: 25864598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twelve-month course and outcome of methamphetamine-induced psychosis compared with first episode primary psychotic disorders.
    Hajebi A; Amini H; Kashani L; Sharifi V
    Early Interv Psychiatry; 2018 Oct; 12(5):928-934. PubMed ID: 27991722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.